Middle East & Africa Neurotoxins Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

No. of Pages: 105    |    Report Code: BMIRE00028646    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Neurotoxins Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Neurotoxins Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Neurotoxins Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Neurotoxins Market Regional Analysis

6.1 Middle East & Africa Neurotoxins Market Overview
6.2 Middle East & Africa Neurotoxins Market Revenue 2021-2028 (US$ Million)
6.3 Middle East & Africa Neurotoxins Market Forecast Analysis

7. Middle East & Africa Neurotoxins Market Analysis – by Product Type

7.1 Botox
  • 7.1.1 Overview
  • 7.1.2 Botox: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Dysport
  • 7.2.1 Overview
  • 7.2.2 Dysport: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Xenomin
  • 7.3.1 Overview
  • 7.3.2 Xenomin: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Neurotoxins Market Analysis – by Application

8.1 Therapeutic and Aesthetic
  • 8.1.1 Overview
  • 8.1.2 Therapeutic and Aesthetic: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Neurotoxins Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Therapeutic and Aesthetic: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Specialty Clinics
  • 9.2.1 Overview
  • 9.2.2 Therapeutic and Aesthetic: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dermatology Clinics
  • 9.3.1 Overview
  • 9.3.2 Therapeutic and Aesthetic: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Neurotoxins Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Neurotoxins Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.1.1.1 Middle East & Africa Neurotoxins Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.1.2 South Africa: Middle East & Africa Neurotoxins Market Breakdown, by Application
    • 10.1.1.1.3 South Africa: Middle East & Africa Neurotoxins Market Breakdown, by End User
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Neurotoxins Market Breakdown, by Application
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Neurotoxins Market Breakdown, by End User
  • 10.1.1.3 UAE: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.3.2 UAE: Middle East & Africa Neurotoxins Market Breakdown, by Application
    • 10.1.1.3.3 UAE: Middle East & Africa Neurotoxins Market Breakdown, by End User
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Neurotoxins Market Breakdown, by Application
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Neurotoxins Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Neurotoxins Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Hugel Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Ipsen SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medytox Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Merz Pharma GmbH & Co KGaA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Middle East & Africa Neurotoxins Market

1. AbbVie Inc
2. Hugel Inc
3. Ipsen SA
4. Medytox Inc
5. Merz Pharma GmbH & Co KGaA

middle-east-and-africa-neurotoxins-market